Sean E Harper Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sean E Harper.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sean E Harper. Sean E Harper is EVP, Research & Development in AMGEN INC ($AMGN).
Latest Insider Trading Transactions of Sean E Harper
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 195.71 | 1,525 | 298,458 | 56,082 | 57.6 K to 56.1 K (-2.65 %) |
| Jun 12 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 184.27 | 1,525 | 281,012 | 57,510 | 59 K to 57.5 K (-2.58 %) |
| May 15 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 174.10 | 1,525 | 265,503 | 59,035 | 60.6 K to 59 K (-2.52 %) |
| May 07 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 169.43 | 736 | 124,700 | 60,560 | 61.3 K to 60.6 K (-1.20 %) |
| May 01 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | A | 177.46 | 34,702 | 6,158,217 | 34,702 | |
| May 01 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 4,508 | 0 | 61,296 | 56.8 K to 61.3 K (+7.94 %) |
| Apr 16 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 172.68 | 1,525 | 263,337 | 56,788 | 58.3 K to 56.8 K (-2.62 %) |
| Mar 27 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 176.08 | 7,549 | 1,329,228 | 58,313 | 65.9 K to 58.3 K (-11.46 %) |
| Mar 19 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 189.75 | 1,525 | 289,369 | 65,682 | 67.2 K to 65.7 K (-2.27 %) |
| Mar 09 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 15,118 | 0 | 67,207 | 52.1 K to 67.2 K (+29.02 %) |
| Feb 15 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 174.18 | 1,525 | 265,625 | 52,089 | 53.6 K to 52.1 K (-2.84 %) |
| Feb 01 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 191.27 | 606 | 115,910 | 53,614 | 54.2 K to 53.6 K (-1.12 %) |
| Feb 01 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 198.00 | 453 | 89,694 | 54,200 | 54.7 K to 54.2 K (-0.83 %) |
| Jan 17 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 185.62 | 1,525 | 283,071 | 54,673 | 56.2 K to 54.7 K (-2.71 %) |
| Dec 12 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 176.83 | 1,525 | 269,666 | 56,106 | 57.6 K to 56.1 K (-2.65 %) |
| Nov 14 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 171.58 | 1,525 | 261,660 | 57,631 | 59.2 K to 57.6 K (-2.58 %) |
| Oct 10 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 185.95 | 1,525 | 283,574 | 59,156 | 60.7 K to 59.2 K (-2.51 %) |
| May 03 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | A | 162.60 | 40,305 | 6,553,593 | 40,305 | |
| May 03 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 4,551 | 0 | 60,496 | 55.9 K to 60.5 K (+8.13 %) |
| Mar 28 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 166.04 | 12,128 | 2,013,733 | 55,945 | 68.1 K to 55.9 K (-17.82 %) |
| Mar 09 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 23,092 | 0 | 67,866 | 44.8 K to 67.9 K (+51.57 %) |
| Feb 02 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 154.43 | 668 | 103,159 | 44,774 | 45.4 K to 44.8 K (-1.47 %) |
| Jan 31 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 157.16 | 513 | 80,623 | 45,442 | 46 K to 45.4 K (-1.12 %) |
| Jan 31 2017 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 157.16 | 1,056 | 165,961 | 45,955 | 47 K to 46 K (-2.25 %) |
| May 05 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | A | 156.35 | 38,112 | 5,958,811 | 38,112 | |
| May 05 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 4,477 | 0 | 46,725 | 42.2 K to 46.7 K (+10.60 %) |
| May 03 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 158.00 | 21,875 | 3,456,134 | 42,248 | 64.1 K to 42.2 K (-34.11 %) |
| Apr 29 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 162.85 | 1,659 | 270,168 | 64,123 | 65.8 K to 64.1 K (-2.52 %) |
| Mar 29 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 149.24 | 23,785 | 3,549,673 | 65,782 | 89.6 K to 65.8 K (-26.56 %) |
| Mar 04 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 45,268 | 0 | 89,162 | 43.9 K to 89.2 K (+103.13 %) |
| Feb 01 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 152.73 | 651 | 99,427 | 43,894 | 44.5 K to 43.9 K (-1.46 %) |
| Feb 01 2016 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 150.47 | 999 | 150,320 | 44,281 | 45.3 K to 44.3 K (-2.21 %) |
| Apr 28 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 167.91 | 1,575 | 264,458 | 45,280 | 46.9 K to 45.3 K (-3.36 %) |
| Apr 28 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 167.91 | 1,065 | 178,824 | 46,855 | 47.9 K to 46.9 K (-2.22 %) |
| Apr 23 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 171.58 | 28,000 | 4,804,240 | 47,920 | 75.9 K to 47.9 K (-36.88 %) |
| Mar 31 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 160.55 | 28,624 | 4,595,583 | 75,920 | 104.5 K to 75.9 K (-27.38 %) |
| Mar 06 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 54,577 | 0 | 104,162 | 49.6 K to 104.2 K (+110.07 %) |
| Feb 03 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 3,940 | 0 | 49,585 | 45.6 K to 49.6 K (+8.63 %) |
| Jan 30 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 158.89 | 35 | 5,561 | 45,645 | 45.7 K to 45.6 K (-0.08 %) |
| Jan 30 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 158.89 | 928 | 147,450 | 45,680 | 46.6 K to 45.7 K (-1.99 %) |
| Jan 05 2015 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 160.63 | 13,046 | 2,095,579 | 46,608 | 59.7 K to 46.6 K (-21.87 %) |
| Aug 07 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 127.30 | 14,000 | 1,782,126 | 59,503 | 73.5 K to 59.5 K (-19.05 %) |
| Apr 29 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 111.41 | 56 | 6,239 | 73,407 | 73.5 K to 73.4 K (-0.08 %) |
| Apr 29 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 111.41 | 1,490 | 166,001 | 73,463 | 75 K to 73.5 K (-1.99 %) |
| Apr 29 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 111.41 | 601 | 66,957 | 74,953 | 75.6 K to 75 K (-0.80 %) |
| Apr 29 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 113.72 | 1,034 | 117,586 | 75,554 | 76.6 K to 75.6 K (-1.35 %) |
| Mar 18 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 123.96 | 7,683 | 952,385 | 76,588 | 84.3 K to 76.6 K (-9.12 %) |
| Mar 07 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 14,724 | 0 | 84,163 | 69.4 K to 84.2 K (+21.20 %) |
| Feb 04 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 5,044 | 0 | 69,439 | 64.4 K to 69.4 K (+7.83 %) |
| May 06 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 50.44 | 8,000 | 403,520 | 0 | |
| May 06 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 106.32 | 8,000 | 850,590 | 64,180 | 72.2 K to 64.2 K (-11.08 %) |
| May 06 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 50.44 | 8,000 | 403,520 | 72,180 | 64.2 K to 72.2 K (+12.46 %) |
| Apr 30 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 108.38 | 588 | 63,727 | 64,180 | 64.8 K to 64.2 K (-0.91 %) |
| Apr 30 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 108.66 | 601 | 65,305 | 64,768 | 65.4 K to 64.8 K (-0.92 %) |
| Apr 29 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 104.93 | 1,034 | 108,498 | 65,369 | 66.4 K to 65.4 K (-1.56 %) |
| Mar 19 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 92.18 | 6,918 | 637,701 | 66,403 | 73.3 K to 66.4 K (-9.44 %) |
| Mar 08 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 13,257 | 0 | 73,238 | 60 K to 73.2 K (+22.10 %) |
| Jan 30 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 7,477 | 0 | 59,981 | 52.5 K to 60 K (+14.24 %) |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 69.78 | 14,400 | 1,004,832 | 0 | |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 71.88 | 16,109 | 1,157,915 | 0 | |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 58.43 | 8,000 | 467,440 | 16,000 | |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 71.88 | 1,391 | 99,985 | 0 | |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 82.33 | 39,900 | 3,285,087 | 52,432 | 92.3 K to 52.4 K (-43.21 %) |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 69.78 | 14,400 | 1,004,832 | 84,332 | 69.9 K to 84.3 K (+20.59 %) |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 71.88 | 16,109 | 1,157,915 | 69,932 | 53.8 K to 69.9 K (+29.93 %) |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 58.43 | 8,000 | 467,440 | 61,823 | 53.8 K to 61.8 K (+14.86 %) |
| Jul 31 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 71.88 | 1,391 | 99,985 | 53,823 | 52.4 K to 53.8 K (+2.65 %) |
| May 03 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 50.44 | 8,000 | 403,520 | 8,000 | |
| May 03 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 42.13 | 6,000 | 252,780 | 0 | |
| May 03 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 71.17 | 6,758 | 480,967 | 52,387 | 59.1 K to 52.4 K (-11.43 %) |
| May 03 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 71.17 | 4,695 | 334,143 | 59,145 | 63.8 K to 59.1 K (-7.35 %) |
| May 03 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 50.44 | 8,000 | 403,520 | 63,840 | 55.8 K to 63.8 K (+14.33 %) |
| May 03 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 42.13 | 6,000 | 252,780 | 55,840 | 49.8 K to 55.8 K (+12.04 %) |
| May 01 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 71.64 | 2,545 | 182,324 | 49,840 | 52.4 K to 49.8 K (-4.86 %) |
| May 01 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 71.64 | 526 | 37,683 | 52,385 | 52.9 K to 52.4 K (-0.99 %) |
| May 01 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 8,654 | 0 | 52,911 | 44.3 K to 52.9 K (+19.55 %) |
| Apr 30 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 70.19 | 514 | 36,078 | 44,257 | 44.8 K to 44.3 K (-1.15 %) |
| Mar 20 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 68.26 | 1,519 | 103,687 | 44,771 | 46.3 K to 44.8 K (-3.28 %) |
| Mar 15 2012 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 4,140 | 0 | 46,290 | 42.2 K to 46.3 K (+9.82 %) |
Page: 1